Literature DB >> 26744664

A case of Lemierre's syndrome with septic shock and complicated parapneumonic effusions requiring intrapleural fibrinolysis.

Daniel P Croft1, Sean M Philippo1, Paritosh Prasad1.   

Abstract

Lemierre's syndrome is a septic thrombophlebitis of the internal jugular vein, which can lead to severe systemic illness. We report a case of an otherwise healthy 26-year-old man who suffered from pharyngitis followed by septic shock requiring intubation and vasopressor support from Fusobacterium necrophorum bacteremia. The septic emboli to his lungs caused complicated bilateral parapneumonic effusions, which recurred after initial drainage. He required bilateral chest tubes and intrapleural tPA to successfully drain his effusions. His fever curve and overall condition improved with the resolution of his effusions and after a 33-day hospitalization, he recovered without significant disability. The severity of his illness and difficult to manage complicated parapneumonic effusions were the unique facets of this case. Using an evidence-based approach of tPA and DNase for complicated parapneumonic effusions in Lemierre's syndrome can be safe and effective.

Entities:  

Keywords:  Chest tube; Critical care; DNase, deoxyribonuclease; ED, Emergency Department; Fibrinolysis; MIST, Multicenter Intrapleural Sepsis Trial; Pleural effusion; Septic thrombophlebitis; Shock; VATS, video-assisted thoracoscopic surgery; tPA, tissue plasminogen activator

Year:  2015        PMID: 26744664      PMCID: PMC4681974          DOI: 10.1016/j.rmcr.2015.08.007

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Lemierre's syndrome describes a septic thrombophlebitis of the internal jugular vein in the setting of an oropharyngeal infection [1]. This syndrome was originally described by André Lemierre as “anaerobic postanginal septicaemias” occurring in young healthy adults [2] and has been increasingly reported in the medical literature over this past decade [3]. The thrombophlebitis of the internal jugular vein can spread septic emboli to the lung, liver, bones, joints and soft tissues with resultant fever and complications specific to the organs involved [4]. The inclusion of positive blood cultures or ultrasonographic evidence of clot as part of the definition varies [1]. The organism commonly associated with Lemierre's syndrome is Fusobacterium necroforum, an anaerobic gram-negative bacterium commonly isolated in the oropharynx and upper respiratory tract [5]. The authors present a case of Lemierre's syndrome with special attention to the management of recurrent complicated parapneumonic effusions.

Case report

Our patient is a previously healthy 26-year-old male with a history of tobacco dependence who presented to a local Emergency Department (ED) with fevers, chills, myalgias and sore throat. He was discharged with a presumed viral URI in the setting of a negative rapid strep test. Two weeks later he presented to the ED with a dry cough, pleuritic chest pain and non-specific upper abdominal pain. He had decreased breath sounds and dullness to percussion in bilateral lung bases with no abnormalities on cardiac exam. His peripheral oxygen saturation on room air was above 90% and blood work revealed leukocytosis (12.6 × 103/μL with 7% bands), a hematocrit of 43.9%, and severe thrombocytopenia (platelet count of 7000 × 1000/μL). Also notable were renal insufficiency with a BUN 55 mg/dl and Cr 1.8 mg/dl, a venous lactate of 4.3 mmol/l and an arterial blood gas on room air of pH 7.45, PCO2 33.9 mmHg and PO2 62.3 mmHg. His chest CT showed bilateral pleural effusions and scattered septic emboli (Fig. 1).
Fig. 1

A. Axial view of a chest CT on admission showing a cavitary lesion in the left upper lobe (thick red arrow) and bilateral pleural effusions (thin blue arrows). B. Coronal view of a chest CT showing similar findings as the axial images of a cavitary left upper lobe lesion (thick red arrow) with focus on right sided consolidation (double thin blue arrows) and smaller left sided effusion (Single thin blue arrow). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

He rapidly developed septic shock requiring vasopressors and intubation. He was transferred to our institution, initially for consideration for plasmapheresis due to concern for idiopathic thrombocytopenic purpura. However, on arrival, Lemierre's syndrome was suspected, prompting empiric treatment with Metronidazole and Ampicillin-sulbactam without anticoagulation due to thrombocytopenia. Blood cultures from the transferring hospital later grew F. necroforum. A CT scan of his neck revealed a mild filling defect of the right internal jugular vein. Despite blood culture clearance, he had ongoing fevers and leukocytosis in the setting of recurrent bilateral complicated parapneumonic effusions (pH of 7.0 and LDH of over 5000U/L bilaterally), prompting placement of bilateral chest tubes. In consultation with the thoracic surgery service, intra-thoracic tissue plasminogen activator (tPA) was administered (alteplase 12.5 mg twice daily) for 3 days to successfully drain each effusion (Fig. 2). Video-assisted thoracoscopic surgery (VATS) was not required. After seventeen days, he was extubated, his fevers abated and platelet count slowly recovered. After a 33-day hospitalization, he was discharged on a course of Amoxicillin-clavulanate for a total course of 5 weeks after definitive drainage with outpatient follow up in another state.
Fig. 2

A. Axial view of a chest CT after removal of chest tubes with evidence of resolving pleural effusions and improving areas of cavitation prior to discharge (thick red arrow). B. Coronal view of a chest CT following chest tube removal showing improvement in bilateral effusions and septic emboli. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Discussion

This case was unique due to the severity of his illness and the use of tPA for bilateral complicated parapneumonic effusions. He required vasopressors for septic shock in addition to intubation for acute respiratory distress syndrome (under 10% of cases reported) [1]. The presence of pleural involvement with septic emboli is common with an incidence up to 92%, with empyemas present in 17–27% of Lemierre's syndrome cases [1], [5]. Multiple studies in adults described chest tube placement for Lemierre's (with culture positive Fusobacterium necrophorum) without tPA administration or VATS [6], [7]. Only one study noted use of tPA (streptokinase) with success in avoiding surgery in a complicated parapneumonic effusion [8]. If an empyema is present in Lemierre's syndrome, minimally invasive VATS [9] or even thoracotomy with decortication [10], [11] can be required. Management of complicated parapneumonic effusions is an area of active discussion in the medical literature. The ability of intra-pleural tPA to break down septations and deoxyribonuclease (DNase) to decrease the fluid viscosity is established [12]. However, guidelines addressing tPA-DNase use are debated with proponents of this practice citing improved drainage of the effusions in the MIST II trial [13] and others contending that VATS is an effective option for management of empyema and should supercede drainage with chest tubes or intrapleural fibrinolytics [14].

Conclusion

The use of tPA-DNase can be an effective and safe treatment strategy for the complicated parapneumonic effusions in patients with Lemierre's syndrome. Given the severity of illness possible from pulmonary involvement in Lemierre's syndrome, the authors propose that chest tubes and fibrinolytics should be considered when complicated parapneumonic effusions arise.

Conflict of interest statement

No conflict of interest exists for any author participating in this article.

Funding information

We appreciate the support of our NIH training grant T32 HL066988.

Other contributions

The authors would like to thank Kristin Lasita for assistance with the editing of our figures.

Financial disclosures

The authors DP, SP and PP have neither relevant financial disclosures nor any conflicts of interest related to this article.
  11 in total

1.  Lemierre's syndrome with bilateral empyema thoracis.

Authors:  M Alifano; N Venissac; F Guillot; J Mouroux
Journal:  Ann Thorac Surg       Date:  2000-03       Impact factor: 4.330

Review 2.  Lemierre's syndrome: more than a historical curiosa.

Authors:  T Riordan; M Wilson
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

3.  Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes.

Authors:  John P Corcoran; Najib M Rahman
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

4.  Lemierre syndrome: two cases requiring surgical intervention.

Authors:  Matthew Murray; Tim Stevens; Alan Herford; Jeff Roberts
Journal:  J Oral Maxillofac Surg       Date:  2012-07-24       Impact factor: 1.895

5.  Fusobacterium necrophorum-induced sepsis: an unusual case of Lemierre's syndrome.

Authors:  P M Kuduvalli; C M Jukka; M Stallwood; C Battersby; T Neal; G Masterson; G Marx
Journal:  Acta Anaesthesiol Scand       Date:  2005-04       Impact factor: 2.105

6.  [Pneumonia caused by Fusobacterium necrophorum: is Lemierre syndrome still current?].

Authors:  Dolunay Gülmez; Sehnaz Alp; Arzu Topeli İskit; Murat Akova; Gülşen Hasçelik
Journal:  Mikrobiyol Bul       Date:  2011-10       Impact factor: 0.622

7.  Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990-1995.

Authors:  L H Hagelskjaer; J Prag; J Malczynski; J H Kristensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

Review 8.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 9.  Lemierre's syndrome: A systematic review.

Authors:  Peter D Karkos; Sheetal Asrani; Christos D Karkos; Samuel C Leong; Evangelia G Theochari; Thalia D Alexopoulou; Assimakis D Assimakopoulos
Journal:  Laryngoscope       Date:  2009-08       Impact factor: 3.325

10.  Intrapleural use of tissue plasminogen activator and DNase in pleural infection.

Authors:  Najib M Rahman; Nicholas A Maskell; Alex West; Richard Teoh; Anthony Arnold; Carolyn Mackinlay; Daniel Peckham; Chris W H Davies; Nabeel Ali; William Kinnear; Andrew Bentley; Brennan C Kahan; John M Wrightson; Helen E Davies; Clare E Hooper; Y C Gary Lee; Emma L Hedley; Nicky Crosthwaite; Louise Choo; Emma J Helm; Fergus V Gleeson; Andrew J Nunn; Robert J O Davies
Journal:  N Engl J Med       Date:  2011-08-11       Impact factor: 91.245

View more
  2 in total

1.  Some neck swellings are serious; a case of Lemierre's Syndrome.

Authors:  Ali Raza Ghani; Mohsin Hamid; Ahsan Raza; Rizwan Naseer; Joseph Crocetti
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-09-19

2.  Early Diagnosis and Antibiotic Treatment Combined with Multicomponent Hemodynamic Support for Addressing a Severe Case of Lemierre's Syndrome.

Authors:  Andreaserena Recchia; Marco Cascella; Sabrina Altamura; Felice Borrelli; Nazario De Nittis; Elisabetta Dibenedetto; Maria Labonia; Giovanna Pavone; Alfredo Del Gaudio
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.